EUVIMEDEUVIMED entdecken
Crossref

Simultaneous quantification of losartan potassium and its active metabolite, EXP3174, in rabbit plasma by validated HPLC–PDA

Taha U Wani, Khalid B Mir, Arun Raina, Alamgir A Dar iD, Ishrat Jan iD, Nisar A Khan, Taseen A Wani, Javid A Sofi, G I Hassan, Hesham S Almoallim, Sulaiman Ali Alharbi, Mohammad Javed Ansari und 3 weitere

Biomedical Chromatography · 2023

DOI: 10.1002/bmc.5645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Taha U Wani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Kashmir Srinagar, Kashmir, India. Hauptthemen laut MEDLINE: Losartan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report a novel, accurate and cost‐effective validated analytical method for the quantification of losartan potassium and its active metabolite, EXP 3174, in rabbit plasma by reversed‐phase high‐performance liquid chromatography. Valsartan was used as an internal standard. The method was validated as per International Conference on Harmonization guidelines. The analytes were extracted in rabbit plasma using liquid–liquid extraction technique and analyzed at 247 nm after separation through a reverse‐phase C 18 column. The isocratic mobile phase used is a mixture of acetonitrile, water and glacial acetic acid in the ratio of 60:40:1 v/v/v maintained at pH 3.4. All calibration curves showed a good linear relationship ( r > 0.995) within the test range. Precision was evaluated by intra‐ and interday tests with RSDs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LosartanAnimalsRabbitsChromatography, High Pressure LiquidValsartanQuality ControlReproducibility of Results

Stichwörter der Autor:innen

EXP 3174HPLCICHlosartan potassiummethod validationrabbit plasma

Substanzen

losartan carboxylic acidLosartanValsartan

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Kashmir Srinagar, Kashmir, India.
  • Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu Tawi, India.
  • Research Centre for Residue and Quality Analysis, Sher-e-Kashmir University of Agricultural Sciences and Technology, Shalimar Campus, Srinagar, India.
  • Department of Analytical Chemistry, Guindy Campus, University of Madras, Chennai, India.
  • Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Alamgir A Dar, Ishrat Jan

Förderung

  • King Saud University

Zitieren

APA

Wani, T. U., Mir, K. B., Raina, A., Dar, A. A., Jan, I., Khan, N. A., Wani, T. A., Sofi, J. A., Hassan, G. I., Almoallim, H. S., Alharbi, S. A., Ansari, M. J., Alfarraj, S., Tarique, M., & Dar, S. A. (2023). Simultaneous quantification of losartan potassium and its active metabolite, EXP3174, in rabbit plasma by validated HPLC–PDA. Biomedical Chromatography. https://doi.org/10.1002/bmc.5645

Vancouver

Wani TU, Mir KB, Raina A, Dar AA, Jan I, Khan NA, et al. Simultaneous quantification of losartan potassium and its active metabolite, EXP3174, in rabbit plasma by validated HPLC–PDA. Biomedical Chromatography. 2023. doi:10.1002/bmc.5645

BibTeX
@article{Wani2023,
  author = {Wani, Taha U and Mir, Khalid B and Raina, Arun and Dar, Alamgir A and Jan, Ishrat and Khan, Nisar A and Wani, Taseen A and Sofi, Javid A and Hassan, G I and Almoallim, Hesham S and Alharbi, Sulaiman Ali and Ansari, Mohammad Javed and Alfarraj, Saleh and Tarique, Mohammed and Dar, Showket A},
  title = {Simultaneous quantification of losartan potassium and its active metabolite, EXP3174, in rabbit plasma by validated HPLC–PDA},
  journal = {Biomedical Chromatography},
  year = {2023},
  doi = {10.1002/bmc.5645}
}
Kostenlos starten →